Shawna Nesbitt

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. doi request reprint Lessons in hypertension from new clinical trials
    Shawna D Nesbitt
    University of Texas Southwestern Medical Center, Dallas, TX 75390 8586, USA
    Postgrad Med 121:34-43. 2009
  2. doi request reprint Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study)
    S D Nesbitt
    Division of Hypertension, UT Southwestern Medical Center, Dallas, TX 75390 8586, USA
    J Hum Hypertens 27:445-52. 2013
  3. doi request reprint Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy
    Shawna Nesbitt
    UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 8586, USA
    J Clin Hypertens (Greenwich) 15:247-53. 2013
  4. ncbi request reprint Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reduction
    Shawna D Nesbitt
    Hypertension Division, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8899, USA
    J Clin Hypertens (Greenwich) 9:26-32. 2007
  5. ncbi request reprint Treatment options for prehypertension
    Shawna D Nesbitt
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8899, USA
    Curr Opin Nephrol Hypertens 16:250-5. 2007
  6. ncbi request reprint Hypertension in special populations
    Shawna D Nesbitt
    University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Semin Nephrol 25:210-4. 2005
  7. ncbi request reprint Hypertension in black patients: special issues and considerations
    Shawna D Nesbitt
    The University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Curr Hypertens Rep 7:244-8. 2005
  8. ncbi request reprint Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study
    Shawna D Nesbitt
    Department of Internal Medicine, Division of Hypertension, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8899, USA
    Am J Hypertens 18:980-5. 2005
  9. doi request reprint Overcoming therapeutic inertia in patients with hypertension
    Shawna D Nesbitt
    Internal Medicine Hypertension, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8586, USA
    Postgrad Med 122:118-24. 2010
  10. ncbi request reprint Hypertension in black patients: special issues and considerations
    Shawna D Nesbitt
    The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 8899, USA
    Curr Cardiol Rep 6:416-20. 2004

Research Grants

  1. Oxidative Stress and Genetics of Prehypertension
    Shawna Nesbitt; Fiscal Year: 2004

Detail Information

Publications25

  1. doi request reprint Lessons in hypertension from new clinical trials
    Shawna D Nesbitt
    University of Texas Southwestern Medical Center, Dallas, TX 75390 8586, USA
    Postgrad Med 121:34-43. 2009
    ....
  2. doi request reprint Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study)
    S D Nesbitt
    Division of Hypertension, UT Southwestern Medical Center, Dallas, TX 75390 8586, USA
    J Hum Hypertens 27:445-52. 2013
    ..Treatment was well tolerated, with low rates of peripheral edema. In summary, switching to a treatment algorithm based on AML/OM┬▒HCTZ after failed monotherapy was safe and improved BP control in patients with hypertension and T2DM...
  3. doi request reprint Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy
    Shawna Nesbitt
    UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 8586, USA
    J Clin Hypertens (Greenwich) 15:247-53. 2013
    ..0001). Antihypertensive efficacy was maintained throughout the 24-hour dosing interval. An AML/OM-based regimen was effective in blacks with hypertension uncontrolled on prior monotherapy...
  4. ncbi request reprint Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reduction
    Shawna D Nesbitt
    Hypertension Division, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8899, USA
    J Clin Hypertens (Greenwich) 9:26-32. 2007
    ..Ongoing trials should provide additional guidance on the optimal choice of combination regimens in specific clinical settings...
  5. ncbi request reprint Treatment options for prehypertension
    Shawna D Nesbitt
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8899, USA
    Curr Opin Nephrol Hypertens 16:250-5. 2007
    ..Prehypertension is a recognized stage of blood pressure but treatment standards have not yet been established. This review will focus on the treatment considerations in prehypertension...
  6. ncbi request reprint Hypertension in special populations
    Shawna D Nesbitt
    University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Semin Nephrol 25:210-4. 2005
    ..The special populations addressed include diabetic patients, the elderly, and women...
  7. ncbi request reprint Hypertension in black patients: special issues and considerations
    Shawna D Nesbitt
    The University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    Curr Hypertens Rep 7:244-8. 2005
    ..Based on our current knowledge, aggressive management of hypertension in blacks is critical. This review highlights what is known about various factors affecting hypertension and its treatment in black Americans...
  8. ncbi request reprint Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study
    Shawna D Nesbitt
    Department of Internal Medicine, Division of Hypertension, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8899, USA
    Am J Hypertens 18:980-5. 2005
    ..5 % (men) and >or=41.2% (women)...
  9. doi request reprint Overcoming therapeutic inertia in patients with hypertension
    Shawna D Nesbitt
    Internal Medicine Hypertension, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8586, USA
    Postgrad Med 122:118-24. 2010
    ..Additionally, the rationale for an ongoing treat-to-goal study using a fixed-dose combination of amlodipine/olmesartan medoxomil in patients with hypertension not controlled on monotherapy is provided...
  10. ncbi request reprint Hypertension in black patients: special issues and considerations
    Shawna D Nesbitt
    The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 8899, USA
    Curr Cardiol Rep 6:416-20. 2004
    ..Based on our current knowledge, aggressive management of hypertension in blacks is critical. This review highlights what is known about various factors affecting hypertension and its treatment in black Americans...
  11. ncbi request reprint Overweight as a risk factor in children: a focus on ethnicity
    Shawna D Nesbitt
    University of Texas Southwestern Medical Center at Dallas, Dallas 75390 8899, USA
    Ethn Dis 14:94-110. 2004
    ..This summary article reviews the data on cardiovascular risk factors and overweight in ethnic children and adolescents, and culminates in a practical algorithm for evaluating overweight children for cardiovascular risk...
  12. ncbi request reprint Perspectives on prehypertension
    Shawna D Nesbitt
    Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390 8899, USA
    J Cardiometab Syndr 1:364-5. 2006
    ..The potential for success in reducing cardiovascular events is great, given the prevalence of prehypertension and the likelihood of progression...
  13. ncbi request reprint Feasibility of treating prehypertension with an angiotensin-receptor blocker
    Stevo Julius
    University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, Ann Arbor, MI 48106, USA
    N Engl J Med 354:1685-97. 2006
    ..Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension...
  14. doi request reprint Improving adherence with amlodipine/atorvastatin therapy: IMPACT study
    Saran Oliver
    University of Texas Southwestern Medical Center, Dallas, TX, USA
    J Clin Hypertens (Greenwich) 13:598-604. 2011
    ..This trial demonstrates that these goals can be achieved similar to other groups in indigent African Americans with high-risk hypertension and dyslipidemia...
  15. ncbi request reprint Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study
    Stevo Julius
    Department of Internal Medicine, Division of Hypertension, University of Michigan Medical Center, 3918 Taubman Center, Ann Arbor, MI 48109 0356, USA
    J Am Coll Cardiol 43:1047-55. 2004
    ..We report on a subanalysis of the effects of losartan and atenolol on cardiovascular events in black patients in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study...
  16. ncbi request reprint Pathogenesis of hypertension in African Americans
    Shawna Nesbitt
    Internal Medicine Hypertension Division, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Congest Heart Fail 10:24-9. 2004
    ..Obesity, especially in African-American women, may be closely related to hypertension as a result of sympathetic nervous system stimulation...
  17. ncbi request reprint Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome
    Fiemu E Nwariaku
    Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75390 9156, USA
    Arch Surg 141:497-502; discussion 502-3. 2006
    ..Adrenal vein sampling is superior to computed tomography for subtype differentiation of primary hyperaldosteronism...
  18. ncbi request reprint Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism
    Richard J Auchus
    Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390 8857, USA
    J Clin Endocrinol Metab 92:2648-51. 2007
    ....
  19. pmc Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism
    Andrew C Kontak
    Cardiology Division, University of Texas Southwestern Medical Center, Dallas, Texas 75390 8586, USA
    J Clin Endocrinol Metab 95:4756-61. 2010
    ..Aldosterone has been shown to exert a central sympathoexcitatory action in multiple animal models, but evidence in humans is still lacking...
  20. ncbi request reprint A "gender blind" relationship of lean body mass and blood pressure in the Tecumseh study
    Stevo Julius
    Division of Hypertension, University of Michigan, Ann Arbor 48109 0356, USA
    Am J Hypertens 15:258-63. 2002
    ..Body size correlates positively with blood pressure (BP) but there is controversy about the roles of obesity versus muscularity in this relationship...
  21. doi request reprint Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement
    John M Flack
    Department of Internal Medicine, Wayne State University, Detroit, Mich, USA
    Hypertension 56:780-800. 2010
    ....
  22. ncbi request reprint An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY)
    Setareh A Williams
    AstraZeneca LP, Wilmington, DE 19850, USA
    J Clin Hypertens (Greenwich) 10:436-42. 2008
    ..05). In TROPHY, patients with prehypertension had relatively high baseline HRQL, and HRQL was maintained with the angiotensin receptor blocker candesartan over both the 2-year treatment period and a total 4-year trial period...
  23. ncbi request reprint Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
    Michael H Olsen
    Department of Clinical Physiology and Nuclear Medicine, Glostrup University Hospital, Copenhagen, Denmark
    J Hypertens 23:891-8. 2005
    ..We hypothesized that treatment with losartan as compared to atenolol would improve insulin sensitivity through regression of peripheral vascular hypertrophy/rarefaction...
  24. ncbi request reprint Nitrates as adjunct hypertensive treatment: a possible answer to resistant systolic hypertension
    Shawna D Nesbitt
    Hypertension 45:352-3. 2005
  25. ncbi request reprint Obesity: putting our children at risk
    Shawna D Nesbitt
    Ethn Dis 12:320-1. 2002

Research Grants3

  1. Oxidative Stress and Genetics of Prehypertension
    Shawna Nesbitt; Fiscal Year: 2004
    ..abstract_text> ..